The CAPTION system joins the company's biologic portfolio, which
includes the EXOGEN 4000+(TM) ultrasound bone healing system and SUPARTZ(R)
treatment the world's number one joint fluid therapy for pain reduction of
the knee.
(TM) Trademark of Smith & Nephew.
SUPARTZ is a registered trademark of the Seikagaku Corporation.
About us
Smith & Nephew is a global medical technology business, specializing in Orthopaedic Trauma & Clinical Therapies, Orthopaedic Reconstruction, Endoscopy and Advanced Wound Management products. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company operates in 32 countries around the world. Annual sales in 2007 were nearly $3.4 billion.
Forward-Looking Statements
This press release contains certain "forward-looking statements" within
the meaning of the US Private Securities Litigation Reform Act of 1995. In
particular, statements regarding planned growth in our business and in our
trading margins discussed under "Outlook" are forward-looking statements as
are discussions of our product pipeline. These statements, as well as the
phrases "aim", "plan", "intend", "anticipate", "well-placed", "believe",
"estimate"
'/>"/>
| SOURCE Smith & Nephew, Inc. Copyright©2008 PR Newswire. All rights reserved |